Skip to main content
. 2021 May 29;22:183–195. doi: 10.1016/j.omtm.2021.05.012

Table 2.

LLOQ determination

Donor/peptide combination Donor ID Peptide stimulus Mean SFU/wella No. runs with CV ≤30%
1 Donor 4 CMVpp65b 221.5 6
2 Donor 1 FVIIIc pool 2 82.2 6
3 Donor 1 FVIII pool 3 75.1 6
4 Donor 4 FVIII pool 4 44.4 6
5 Donor 5 FVIII pool 4 41.8 0
6 Donor 4 FVIII pool 2 39.3 3
7 Donor 5 FVIII pool 2 37.7 0
8 Donor 5 FVIII pool 1 33.2 1
9 Donor 2 FVIII pool 2 <LOD N/A
10 Donor 2 CMVpp65 <OD N/A
11 Donor 3 FVIII pool 2 <LOD N/A
12 Donor 3 CMVpp65 <LOD N/A
13 Donor 6 FVIII pool 2 <LOD N/A
14 Donor 6 CMVpp65 <LOD N/A

Bold indicates values selected as LLOQ.

a

Cell-plating density was 200,000 PBMCs/well and viability was ≥70% for all donor samples across all runs.

b

CMVpp65, 65 kDa phosphoprotein of cytomegalovirus.

c

FVIII, transgene product.